Netripples Software Ltd

AGM Proceedings & Key Resolutions

• 32nd AGM held Sep 30, 2026, 11:00–12:00, Hyderabad.
• Adoption of Audited Financial Statements for FY2025-26 approved.
• Re-appointment of Statutory Auditors M/s BGS & Associates approved.
• Approval of strategic measures for BSE trading revocation and compliance.
• Adoption and noting of Secretarial Audit Report.
• Scrutinizer appointed for AGM: CS Kode Hemchand.
• All resolutions passed with requisite majority (100% in favour).
• Shareholders on record: 1,206; attendees: 18.

Financial snapshot

• Revenue from operations: Rs 7,17,64,619 for FY2025-26.
• Net profit after tax: Rs 2,72,211.
• Earnings per share (basic): Rs 0.04.
• Reserves & surplus: Rs 3,12,61,555; total equity: Rs 9,94,30,555.

Trading status & AGM

• Trading on BSE is temporarily suspended; revival expected.
• 32nd AGM scheduled for 30 September 2026 in Hyderabad.

Operations & opportunities

• Single operating segment: Application Software and Services.
• Healthcare IT e-commerce portfolio exceeds 75 products.
• Exploring new technology opportunities and AI-enabled services.

Capital structure & liquidity

• Equity share capital: Rs 6,81,69,000; total equity Rs 9,94,30,555.
• Non-current liabilities: Rs 23,61,065; current liabilities: Rs 5,23,750.
• Borrowings: nil; cash and cash equivalents: Rs 46,001.

Governance & compliance

• Board comprises four directors; Audit Committee chaired by Jameela Afreen.
• Remuneration Committee not constituted in 2025-26.
• Secretarial audit: no adverse observations; SEBI LODR compliance.

Audit & controls

• Auditors: M/s BGS & Associates.
• Going concern viewed as a matter of emphasis in the report.
• Key audit matters include revenue recognition and valuation of DTAs.

Outlook & risks

• Outlook focuses on AI-enabled healthcare IT growth and opportunities.
• Emphasis on regulatory compliance and disciplined execution amid macro headwinds.

Meeting Details

• Board meeting scheduled for 31-08-2026 at 10:00 AM in Hyderabad.

Key Agenda Items

• Approval of Annual Report for FY 2025-26 including Directors' Report and Audited Financial Statements and Audit Report.

Other Notes

• AGM scheduled for 30 September 2026.

Filing scope

• Unaudited standalone results for half-year ended 30 September 2025 submitted under Regulation 33.
• Board approved results at 5 November 2025 meeting.
• Includes standalone results, assets and liabilities, cash flow, and limited review report.
• Note: minor revisions to net profit possible for half-year.

Financial highlights HY ended Sep 30 2025

• Quarter revenue: INR 169.66 Lakhs.
• Year-to-date revenue: INR 290.99 Lakhs.
• HY net profit: INR 8.24 Lakhs; EPS: 0.01.
• Total assets: INR 1,019.94 Lakhs; total equity: INR 991.58 Lakhs.

Audit & governance

• Limited Review by BGS & Associates: unmodified opinion.
• Review conducted under SRE 2410; no material misstatement found.

AGM outcome: Secretarial Auditor appointment

• AGM held 30 Sep 2025; approved appointment of M/s CS Hemachand Kode as Secretarial Auditor.
• Auditor: M/s CS Hemachand Kode; Membership 35463, CP 13416.
• Term: 5 consecutive years from 30 Sep 2025 to AGM 2030.
• Remuneration to be determined by Board in consultation with Auditor.
• Mazhar Pasha authorized to file ROC forms and submit to BSE as required.

Capital unchanged confirmation

• Confirmation dated 24 Aug 2026 that listed and issued capital match exchange and depository records.

Cash flow FY2024-25 (Audited)

• Net cash from operating activities for FY2024-25: ₹8.89 lakh.
• Net cash used in investing activities: ₹4.53 lakh.
• Net cash used in financing activities: ₹0.01 lakh.
• Net increase in cash and cash equivalents: ₹4.35 lakh; ending cash ₹4.77 lakh.
• Starting cash at beginning of period: ₹0.42 lakh.
• Key working capital moves: receivables +₹4.51 lakh; inventories -₹4.28 lakh; payables +₹2.74 lakh.
• Depreciation and amortisation: ₹4.45 lakh.
• Income taxes paid: ₹0.24 lakh.

Subject & approvals

• Board approved corrected cash flows and limited review report on 8 May 2026.
• Submission under Regulation 33 SEBI LODR for quarter ended 31 March 2026.
• Audited cash flow statement for quarter ended 31 March 2026 submitted.

Key financial details

• Profit before tax: ₹2.97 Lakhs.
• Net cash from operations: ₹0.42 Lakhs.
• Investing cash flow: ₹-9.44 Lakhs.
• Ending cash and cash equivalents: ₹-4.25 Lakhs.
• Beginning cash and cash equivalents: ₹4.77 Lakhs.

Audit opinion & regulatory

• Auditor's report: true and fair view for quarter/year ended 31 March 2026.
• Regulatory compliance: Regulation 33 of SEBI LODR noted.

Financial highlights

• Q1 FY2027 revenue from operations ₹181.86 lakh; QoQ fell ~10% from ₹202.00 lakh.
• Net profit after tax ₹6.41 lakh; previously a loss in the prior quarter.
• EPS (basic and diluted) ₹0.09 for the quarter.
• Major expense: OnSite expenses ₹168.45 lakh; total expenses ₹175.45 lakh.
• Board approved unaudited results on 10 Aug 2026.
• Limited Review by BGS & ASSOCIATES; unmodified opinion.
• Paid-up equity share capital ₹681.69 lakh.

Meeting Details

• Meeting on 10 August 2026 at 09:00 am; location not disclosed.

Key Agenda Items

• Approve unaudited Q1 FY2026-27 financial results for quarter ended 30 June 2026.

Other Notes

• No additional material governance actions disclosed in the notice.